Newsletter Subject

đź“° NASDAQ: BSGM - Executes Purchase Agreement!

From

topstocktips.com

Email Address

editor@topstocktips.com

Sent On

Fri, Oct 7, 2022 02:22 PM

Email Preheader Text

ALERT: NASDAQ: BSGM As BSGM gains MOMENTUM Today even though Overall Market is tumbling, BSGM just a

[View online]( [UNSUBSCRIBE]( ALERT: NASDAQ: BSGM As BSGM gains MOMENTUM Today even though Overall Market is tumbling, BSGM just announced some HUGE NEWS! BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base Leading medical center in San Antonio acquires BioSig’s novel digital signal processing technology for arrhythmia care Westport, CT, Oct. 07, 2022 (GLOBE NEWSWIRE) -- [BioSig Technologies, Inc.]( BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that San Antonio Methodist Hospital has acquired the PURE EP™ System. The acquisition, one of many in the pipeline, reaffirms the continued expansion of BioSig’s U.S. footprint and customer base. "As we continue to advance the national commercial rollout of the PURE EP™ System, we are thrilled to introduce our technology to Methodist Hospital in San Antonio,” said Gray Fleming, Chief Commercial Officer, BioSig Technologies, Inc. “We believe that the PURE EP™ System enhances EP lab infrastructure by integrating with existing workflows and delivers critical signals of interest that are not visible on conventional systems.” “PURE EP™ delivers great value to our lab across many different types of ablations. By uncovering new levels of clarity of intracardiac signals, PURE EP™ opens doors to the benefits of signal processing in the digital domain,” commented David N. Pederson, MD, Clinical Cardiac Electrophysiologist, Methodist Hospital, San Antonio, TX. Link to Full Press Release: Previous email below incase you missed it: Discover Why This Little-Known Cardiology Device Company Could See Heart Stopping Growth as Insiders Load Up… Greetings Investors, One of the big messages that became clear from Moderna Inc. (NASDAQ: MRNA) seeing big gains amid the pandemic was that the company was at the front and center of a dire trend. That’s why many investors are on a quest to find companies that are focused on the biggest trends in healthcare and exhibit major growth potential. There is a huge and radical push to simplify and reduce costs in the management of chronic diseases, which in the United States eats up a lot of healthcare spending. One rising arena in healthcare that isn't getting talked about enough is bioelectronic medicine, which is a rapidly growing segment of healthcare that explores how targeted electrical signals can harness the body’s natural mechanisms to diagnose and treat a range of diseases. With that said, there is a quietly trading NASDAQ company in this rising arena called BioSig Technologies, Inc. (NASDAQ: BSGM) that is trading under $1 and has technology aimed to help prevent a major health crisis, saving significant costs for both patients and the healthcare system. There’s a good reason why insiders in the company are loading up on shares. Orders are piling up, there’s a 10-year strategic agreement with the world-famous Mayo Clinic and other big developments! Everybody needs healthcare -- or will at some point. And when there’s something everyone needs, there’s a huge opportunity for investors…. Not to mention that this arena is often described as recession-proof. BioSig Technologies, Inc. (NASDAQ: BSGM) is targeting the [anticipated $15.7B electrophysiology (EP) market]( and is seeking to serve a vital market with a device that could be a game changer! BSGM is on a solid path to commercial growth and orders are coming in as the company publishes impressive clinical results, expands its product pipeline, and grows internationally! [READ FULL PROFILE ON NASDAQ: BSGM](     Copyright 2022 © TopStockTips is owned and operated by Top Stock Tips Ltd. [Disclaimer and PrivacyÂ]( more Information please contact editor@topstocktips.com This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. This communication includes advertising material and PAID ADVERTISEMENTS provided to our subscribers. Copyright 2022 © TopStockTips.com is 50% owned and operated by the owner of CareBear Marketing Group LLC. Disclaimer and Privacy For more Information please contact Support@TopStockTips.com Company Address: 26 Downing Street, Newark NJ 07105. This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment. Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.  CareBear Marketing Group, its managers, its employees, affiliates, and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above. To the maximum extent permitted by law, the Company disclaims all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete, or unreliable, or result in any investment or other losses. You received this message as part of your subscription to TST. TST is a free financial news and information website. We do not directly sell any products or offer any personal financial advice, nor do we advocate the purchase or sale of any security or investment for any specific individual. We also do not make any guarantee or warranty about what is advertised above. If you have questions or concerns about a product you’ve seen in one of our emails, we encourage you to reach out to that company directly.  Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by CareBear Marketing Group. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “TST” refers to CareBear Marketing Group. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here. We do not own any shares in BSGM. We have been currently compensated up Seventy-Five Thousand Dollars Cash ($75,000) via bank wire transfer from a third-party Legends Media Inc for a 2 Day Marketing Program regarding BSGM with a start date of 10/06/2022 to 10/07/2022. We have been previously compensated Seventy-Five Thousand Dollars Cash ($75,000) via bank wire transfer from a third-party Open Market Media Group Inc for a 2 Day Marketing Program regarding BSGM with a start date of 6/22/2022 to 6/23/2022. We have been previously compensated Ten Thousand Dollars Cash ($10,000) via bank wire transfer from a third-party Legends Media Inc for a 1 Day Marketing Program regarding BSGM on 8/29/22 TST’s business model is to receive financial compensation to promote public companies. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TST often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. , Rua Frei Tome de Jesus N18 1Dto, 1700-215, Lisboa, Portugal You may [unsubscribe]( or [change your contact details]( at any time. Powered by:[GetResponse](

EDM Keywords (201)

website warranty volume visible viewed verified variety using used unreliable treat trading time thrilled terms technology targeting take subscription subscribers subject stock speculative soon site simplify shares service serve seen seeking seek security sale said risk result researched research replacement registered recommendation received receive reading reader reach range questions quest purpose purely purchase publication prospectus products product problems privacy preparing precision potential point piling performing patients parties part pandemic owners owner owned otherwise orders operated one omissions offer occur number newsletters newsletter never near missed message mention may market many managers management making make made lot losses lose loading list liquidity likely licensed liability law larger issuer investors investments investment investing investigated invest introduce interest integrating insiders information incorrect incase huge hold healthcare harness guaranteed guarantee getresponse front footprint focused factors explores expected expanding event errors ensure enough end encouraged encourage emails editor editing edited diseases discover disclaimers disclaimer diagnose device day database could correct continue consulting consult concerns completeness compensation company communications communication coming collected clarity change center carry buy bsgm brief body biosig benefits benefit believed believe basis based background author assume arena anything announced also alerts agree afford advocate advisory advise advice advertised advance action acquired accurate ablations ability

Marketing emails from topstocktips.com

View More
Sent On

11/08/2023

Sent On

10/08/2023

Sent On

31/03/2023

Sent On

13/03/2023

Sent On

08/03/2023

Sent On

01/02/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.